Loss of smarce1 expression is a specific diagnostic marker of clear cell meningioma: A comprehensive immunophenotypical and molecular analysis

In conclusion, our series showed, for the first time, that SMARCE1 immunostaining is a highly sensitive biomarker for CCM, useful as a routine diagnostic biomarker. This article is protected by copyright. All rights reserved.

Source: Brain Pathology - May 1, 2017 Category: Neurology Authors: Arnault Tauziede ‐Espariat, Béatrice Parfait, Aurore Besnard, Joëlle Lacombe, Johan Pallud, Sanaa Tazi, Stéphanie Puget, Guillaume Lot, Benoît Terris, Julie Cohen, Michel Vidaud, Dominique Figarella‐Branger, Franck Monnien, Marc Polivka, Homa Adle Tags: Research Article Source Type: research